25 May 2013
Keywords: syntropharma, raises, 4m, second, round, investment, early-stage
Article | 15 September 2008
Syntropharma, an early-stage Scottish drug developer focussed on transdermal patch delivery of reformulated generics, has raised 1.2 million ($2.1 million) in a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.